Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men

被引:10
|
作者
Kido, Ayumu [1 ]
Tamada, Tsutomu [1 ]
Kanomata, Naoki [2 ]
Yamamoto, Akira [1 ]
Miyaji, Yoshiyuki [3 ]
Nagai, Atsushi [3 ]
Sone, Teruki [1 ]
机构
[1] Kawasaki Med Sch, Dept Radiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan
[2] Kawasaki Med Sch, Dept Pathol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan
[3] Kawasaki Med Sch, Dept Urol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan
关键词
Magnetic resonance imaging; Prostate cancer; Tumor detection; Prostate imaging and reporting data system version 2; Dynamic contrast-enhanced MR imaging; RESONANCE-IMAGING CORRELATION; RADICAL PROSTATECTOMY; VERSION; FUSION BIOPSY; IMPACT; CARCINOMA; ACCURACY; PATTERNS; OUTCOMES; TRENDS;
D O I
10.1007/s11604-018-0801-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo clarify clinicopathological features of false-negative clinically significant prostate cancer (csPC) at multiparametric prostate MRI (mpMRI).Methods95 patients with 139 csPC undergoing 3T mpMRI before radical prostatectomy were included. Two radiologists were independently evaluated mpMR images using PI-RADS v2. Clinicopathological findings were compared between (a) detectable and undetectable lesions using overall mpMRI criteria (o-mpMRI criteria) and (b) lesions with early enhancement effect (EEE) and lesions without EEE at DCE-MRI.ResultsThe detection rate of csPS using cutoff value of category 3 or more in PI-RADS v2 for positive lesion was 72.1% (98/136 lesions). In 38 false-negative lesions with less than PI-RADS v2 category 3, the DCE-MRI detected 14 lesions. 17 undetectable lesions on o-mpMR criteria had lower PSA and D'amico risk classification, and higher tumor apparent diffusion coefficient (ADC) than those of 118 detectable lesions (p0.048). 89 lesions with EEE showed higher PSA, tumor size, prostatectomy GS grade, frequency of lesions with GS4+3 and lower tumor ADC than those in 38 lesions without EEE (p0.046).ConclusionTumor detectability of csPC with PI-RADS v2 was limited compared with o-mpMRI criteria in Japanese men. Moreover, false-negative lesions on o-mpMRI criteria were characterized as small in size, low risk and low cellularity.
引用
收藏
页码:154 / 164
页数:11
相关论文
共 50 条
  • [21] Evaluating the risk of clinically significant prostate cancer in lesions detected on multiparametric MRI of the prostate.
    Molokwu, Chidi N.
    Gkikas, Christos
    Lee, Nicola
    Lesniak-Buzon, Joanna
    Ali, Faisal
    Bardgett, Harry
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [22] Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?
    Grey, Alistair D. R.
    Connor, Martin J.
    Tam, Joseph
    Loch, Tillmann
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 1492 - 1500
  • [23] Integration of Polygenic Risk Score (PRS) with multiparametric MRI in men at risk for clinically significant prostate cancer
    Plym, A.
    Madueke, I. C.
    Naik, S.
    Penney, K. L.
    Mucci, L. A.
    Khorasani, R.
    Kibel, A. S.
    EUROPEAN UROLOGY, 2023, 83 : S104 - S105
  • [24] INTEGRATION OF POLYGENIC RISK SCORE (PRS) WITH MULTIPARAMETRIC MRI IN MEN AT RISK FOR CLINICALLY SIGNIFICANT PROSTATE CANCER
    Plym, Anna
    Madueke, Ikenna
    Naik, Sachin
    Penney, Kathryn L.
    Mucci, Lorelei A.
    Khorasani, Rhamin
    Kibel, Adam S.
    JOURNAL OF UROLOGY, 2023, 209 : E1045 - E1045
  • [25] Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer
    Rachael L. Sherrer
    Zachary A. Glaser
    Jennifer B. Gordetsky
    Jeffrey W. Nix
    Kristin K. Porter
    Soroush Rais-Bahrami
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 331 - 336
  • [26] Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer
    Sherrer, Rachael L.
    Glaser, Zachary A.
    Gordetsky, Jennifer B.
    Nix, Jeffrey W.
    Porter, Kristin K.
    Rais-Bahrami, Soroush
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (02) : 331 - 336
  • [27] Shear-wave elastography: role in clinically significant prostate cancer with false-negative magnetic resonance imaging
    Li-Hua Xiang
    Yan Fang
    Jing Wan
    Guang Xu
    Ming-Hua Yao
    Shi-Si Ding
    Hui Liu
    Rong Wu
    European Radiology, 2019, 29 : 6682 - 6689
  • [28] Shear-wave elastography: role in clinically significant prostate cancer with false-negative magnetic resonance imaging
    Xiang, Li-Hua
    Fang, Yan
    Wan, Jing
    Xu, Guang
    Yao, Ming-Hua
    Ding, Shi-Si
    Liu, Hui
    Wu, Rong
    EUROPEAN RADIOLOGY, 2019, 29 (12) : 6682 - 6689
  • [29] The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-Can it rule out clinically significant prostate cancer?
    Abd-Alazeez, Mohamed
    Ahmed, Hashim U.
    Arya, Manit
    Charman, Susan C.
    Anastasiadis, Eleni
    Freeman, Alex
    Emberton, Mark
    Kirkham, Alex
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 45.e17 - 45.e22
  • [30] Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI
    Gan, Jonathan M.
    Kikano, Elias G.
    Smith, Daniel A.
    Rao, Sanjay
    Podury, Ruchika
    Wang, Margaret
    Durieux, Jared C.
    Paspulati, Raj M.
    Ponsky, Lee
    Ramaiya, Nikhil H.
    Tirumani, Sree H.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (05) : 859 - 866